UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group

Autor: Turner, R, Stratton, I, Horton, V, Manley, S, Zimmet, P, Mackay, IR, Shattock, M, Bottazzo, GF, Holman, R

BACKGROUND: Autoantibodies to islet-cell cytoplasm (ICA) and glutamic acid decarboxylase (GADA) can occur in apparently typical, non-insulin dependent diabetes mellitus (type 2). We investigated whether the presence of either or both antibodies chara

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e7704df0a515a61336873af7dd1f8eda
https://ora.ox.ac.uk/objects/uuid:1cab5256-1e7c-4a2d-8842-3f05f05d7f52

The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+

Autor: De Berardinis, P, Londei, M, Kahan, M, Balsano, F, Kontiainen, S, Gale, EA, Bottazzo, GF, Feldmann, M

Twenty-five recently diagnosed insulin-dependent diabetic patients were screened for the presence of activated T lymphocytes using the anti-IL-2 receptor monoclonal antibody; thirteen had elevated levels of activated T lymphocytes. The activated cell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c8e0e2c06ef0f7ed4eef93a6f833e032
https://ora.ox.ac.uk/objects/uuid:388b476f-1d1d-4cd8-8612-f008c85c1bb7

Prognosis and outcome of latent autoimmune diabetes in adults: T1DM or T2DM?

Autor: Zhou, Zhipeng^1,2 (AUTHOR), Xu, Mingyue^1,2 (AUTHOR), Xiong, Pingjie^1,2 (AUTHOR), Yuan, Jing^1,2 (AUTHOR), Zheng, Deqing^1,2 (AUTHOR), Piao, Shenghua^1,2 (AUTHOR) piaow@163.com

Publikováno v: Diabetology & Metabolic Syndrome. 10/7/2024, Vol. 16 Issue 1, p1-8. 8p.

Isolated hypoprolactinemia: The rarest of the rare?

Autor: Khan A; School of Medicine, Department of Pathology, Johns Hopkins Hospital, Ross building - Room 656, 720 Rutland Avenue, Baltimore, MD, USA., Di Dalmazi G; Center for Advanced Studies and Technology (CAST) and Department of Medicine and Aging Science, University 'Gabriele d' Annunzio' of Chieti-Pescara, 66100, Chieti, Italy., Najafian Zahmatkeshan K; Freddie Mac Mortgage Company, McLean, VA, USA., Caturegli P; School of Medicine, Department of Pathology, Johns Hopkins Hospital, Ross building - Room 656, 720 Rutland Avenue, Baltimore, MD, USA. pcat@jhmi.edu.

Publikováno v: Reviews in endocrine & metabolic disorders [Rev Endocr Metab Disord] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.

Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2

Autor: TIBERTI, C, LOCATELLI M, BOSI E, BOTTAZZO GF, BUZZETTI R, CUCINOTTA D, FALORNI A, DOTTA F., GIORDANO, Carla, GALLUZZO, Aldo

OBJECTIVE: The presence of autoantibodies to islet antigens GAD and/or tyrosine phosphatase 2 (IA-2) in type 2 diabetic patients (latent autoimmune diabetes in adults [LADA]) identifies subjects at high risk to develop insulin dependency. The aim of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::4c5e783a733838f7a2e1df92aa9db517
http://hdl.handle.net/10447/2169